Blood study of migraine markers
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old. Men and women can both take part.
- You need to be able to understand written and spoken Scandinavian language well enough to follow the study instructions.
- You must have a doctor's diagnosis of migraine (with or without aura) and have at least one attack a month that needs medication.
- You must be willing to keep a headache diary for up to 6 months.
- You cannot be pregnant, smoke, or have certain other health conditions (like chronic pain or severe psychiatric disorders).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This study looks at tears to find markers that may help diagnose migraine and understand it better. If you have migraine, you may also receive a new class of migraine treatment (anti-CGRP antibodies or gepants) if your doctor recommends it.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.
This study tracks how well new migraine medications (like Aimovig, Emgality, Ajovy, Vyepti, Qulipta, and Nurtec) work in everyday use. It may help you and your doctor understand if these treatments are a good option for your migraines.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.